| Literature DB >> 33538356 |
Shruthi Muthunatarajan1, Sridevi Hanaganahalli Basavaiah2,3, Suchitra M Shenoy3,4, Arvind Natarajan2, Prasanna Mithra3,5, Pooja Kundapur Suresh2,3, Saraswathy Sreeram2,3.
Abstract
INTRODUCTION: In India, infectious diseases are a leading treatable cause of morbidity and mortality. Mangalore being endemic to many vector-borne diseases, their incidence is known to show seasonal variations with sharp increase during monsoon. Leucocytes have substantial role in the immunological pathogenesis of infections.Entities:
Keywords: cell population data; mean neutrophil volume; tropical; vector-borne; volume-conductivity-scatter data
Year: 2021 PMID: 33538356 PMCID: PMC8059744 DOI: 10.1002/jcla.23723
Source DB: PubMed Journal: J Clin Lab Anal ISSN: 0887-8013 Impact factor: 2.352
FIGURE 1WBC Histogram: A: Healthy control: LD and UD discriminators at 35fL and 450fL; first imaginary discriminator T1 at 78‐114fL and second imaginary discriminator T2 at 150fL. F1 peak (between LD and T1) consists of lymphocytes, F2 (between T1 and T2) represents monocytes, eosinophils, basophils and immature granulocytes and F3 (between T1 and LD) represents mature neutrophils. B: Malaria: Presence of pre‐threshold peak at LD (35fL) representing parasitized un‐lysed RBCs that enters WBC chamber is highly characteristic (arrow). There is a shift to right of T1 and obliteration of T2. C: Dengue: There is shift to right of T1 and T2 with widening of F1 peak. D: Typhoid: The shift to right of T1 is mild. The WBC histogram is almost comparable to that seen in healthy control. Similar histograms were noted in leptospirosis and rickettsia
FIGURE 2WBC differential count scatterplot: A: Healthy control scatterplot with separate windows for lymphocytes (blue), monocytes (green), neutrophils (purple) and eosinophils (orange). Note the windows where blasts, variant lymphocytes, immature neutrophils and un‐lysed RBCs can fall. B: Malaria: Lymphocytes plots extend into variant lymphocyte window and monocyte plots extend into blast window. Note the obliteration of clear demarcation between the windows of lymphocytes, neutrophils and monocytes. C: Dengue: Lymphocytes plots are seen extending into variant lymphocyte window and monocyte plots into blast window. Leucopenia was noted in this patient. D: Typhoid fever: The WBC differential count scatterplot was comparable to that seen in healthy control. Similar scatterplots were noted in leptospirosis and rickettsia
FIGURE 3Nucleated RBC plot: A (2D plot), B (3D plot): Healthy control: Axial light loss is plotted on x‐axis and low‐angle light scatter on y‐axis. Measurement of AL2 separates the leucocytes from nucleated red blood cells. Nucleated RBC plot can be used in discrimination of leucocytes (blue) from presence of NRBC (red), platelet (green) clumps, giant platelets and parasitized un‐lysed RBCs. C,D: Malaria: The white arrow (C) and red arrow (D) shows tight green cluster representing parasitized un‐lysed RBCs. E,F: In dengue fever, leptospirosis, typhoid fever and rickettsia, nucleated RBC plot was comparable to that seen in healthy control
Comparison of the demographic details and CBC among the five infections
| Control group | All infections | Malaria | Dengue | Leptospirosis | Typhoid | Rickettsia | |
|---|---|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | |
| Total No. | 324 | 324 | 162 | 100 | 45 | 13 | 4 |
| M:F ratio | 1.5:1 | 2.5:1 | 4.6:1 | 1.1:1 | 4:1 | 1.6:1 | 1:1 |
| RBC parameters | |||||||
| RBC | 4.6 ± 2.3 M,D,L | 4.6 ± 0.8 | 4.7 ± 0.6D,L,T | 4.9 ± 0.8L,T | 4.1 ± 0.8 | 4.3 ± 0.7 | 4.3 ± 0.5 |
| Hb | 12.7 ± 1.9A,M,D | 13.4 ± 2.1 | 13.5±2L | 14 ± 2.2L,T | 12.2 ± 2 | 12.7 ± 1.9 | 12.5 ± 1.9 |
| HCT | NA | 39.1 ± 6.5 | 39.3 ± 5.6D,L | 41 ± 7.3L,T | 34.8 ± 6.2 | 36.6 ± 4.6 | 36.1 ± 5 |
| MCV | NA | 85 ± 7.4 | 84.9 ± 7.4 | 84.6 ± 7.8 | 86.1 ± 7.3 | 84.6 ± 5.4 | 86.8 ± 4 |
| MCH | NA | 29.2 ± 2.9 | 29.2 ± 2.9 | 28.9 ± 3.1L | 29.7 ± 2.9 | 29.1 ± 2.3 | 29.7 ± 2.6 |
| MCHC | NA | 34.2 ± 2 | 34.3±2D | 34 ± 1.3L | 34.5 ± 0.9 | 32.8 ± 6.1 | 34.4 ± 1.1 |
| RDW | NA | 14.3 ± 1.7 | 14.2 ± 1.8L | 14.2±2L | 14.7 ± 1.2 | 14.1 ± 0.6 | 14.2 ± 0.6 |
| RDW‐SD | NA | 42.4 ± 4.6 | 42.3 ± 4.5L | 41.6 ± 4.7L | 44.2 ± 4.6 | 42 ± .3.2L | 43 ± 1.1 |
| Platelet parameters | |||||||
| Platelet | 295 ± 82.1A,M,D,L,T,R | 94.6 ± 71.1 | 99.4±55D,L,T,R | 77 ± 76.8 T,R | 80 ± 79.9 | 190.4 ± 78.8L | 176.5 ± 81.2L |
| MPV | 8.0 ± 0.9A,M,D,L,T,R | 8.9 ± 1.1 | 8.9 ± 1.1 | 9±1L | 8.5 ± 1.2 | 8.8 ± 1.2 | 9.4 ± 1.3 |
| PCT | NA | 0.06 ± 0.06 | 0.06 ± 0.05D | 0.5 ± 0.06 | 0.06 ± 0.07 | 0.4 ± 0.07L | 0.2 ± 0.05 |
| PDW | NA | 17.5 ± 1.2 | 17.4 ± 1.1D | 17.7 ± 1.2 | 17.6 ± 1.4 | 17.1 ± 0.7L | 17.6 ± 0.5 |
| WBC parameters | |||||||
| WBC | 7.6 ± 1.7A,M,D,L,T,R | 6.7 ± 4.3 | 5.5 ± 1.9L,T,R | 6.7±5L,R | 10.7 ± 6.2 | 6.4 ± 1.4 L,R | 11.9 ± 5.7 |
| Neutrophil (%) | 60.2 ± 7.5 M,D,L,R | 62.2 ± 18.8 | 67.9 ± 14.8D,L,T,R | 49 ± 17.7L,T | 73.4 ± 18.9 | 60.2 ± 14.4L,R | 44.9 ± 0.00L |
| Lymphocyte (%) | 28.4 ± 7.0A,M,L,R | 21.9 ± 12.6 | 19.1 ± 10.3D,L,T | 28.7 ± 12.6L,R | 14.3 ± 12.4 | 30.7 ± 12.1L | 15.7 ± 10.8 |
| Monocyte (%) | 7.6 ± 1.5A,M,D | 13.2 ± 8.4 | 10.8 ± 5.1 D,L,T | 20.1 ± 10.1L,T,R | 8.8 ± 4.8 | 8±3R | 6.6 ± 4.5 |
| Eosinophil (%) | 3.2 ± 1.9A,M,D,L,T,R | 1.2 ± 1.7 | 0.9 ± 1.3L,T | 1.5 ± 2.2 T | 1.3 ± 1.4 | 0.7 ± 1.6L | 1.1 ± 1.3 |
| Basophil (%) | 0.6 ± 0.3L,T | 0.7 ± 0.7 | 0.6 ± 0.5L,T | 0.8 ± 1.1L,T | 0.5 ± 0.6 | 0.2 ± 0.3L | 0.3 ± 0.5 |
Abbreviations: A‐all infections; C‐control; D‐dengue; L‐leptospirosis; M:F‐male:female; M‐malaria; No‐number; R‐rickettsia; SD‐standard deviation; T‐typhoid.
The control group was not analysed for these parameters. The control group was used mainly to compare the data related to VCS parameters.
Significantly different among the different groups.
Comparison of mean value of the VCS parameters among the five infections
| VCS | Control | All | Malaria | Dengue | Leptospirosis | Typhoid | Rickettsia |
|---|---|---|---|---|---|---|---|
| Neutrophil parameters | |||||||
| NV | 143.2 ± 9.2A,M,D,L,R | 151.5 ± 10.3* | 152.5 ± 9.6D,L | 147.2 ± 8.5L | 157.1 ± 12.9 | 152.1 ± 11 | 154.5 ± 12.8 |
| NC | 149.2 ± 8.5A,M,D,L | 138.2 ± 5.7* | 138.6 ± 5.3D | 137.3 ± 3.3 | 140.0 ± 8.9 | 141.1 ± 9.6 | 138.6 ± 2.8 |
| NMALS | 139.7 ± 8.6A,M,L,T | 137.1 ± 6.2* | 136.3 ± 6.5D,L | 140.2 ± 4.9L,T,R | 134.0 ± 5.2 | 135.9 ± 5.5 | 133.5 ± 5.1 |
| NUMALS | 135.2 ± 8.3A,M | 137.8 ± 7.2* | 138.1 ± 8.1D,L | 139.7±6L,T | 134.2 ± 6.2 | 134.9 ± 5.7 | 134.0 ± 7.2 |
| NLMALS | 137.2 ± 8.4A,M,D,L,R | 131.9 ± 7.4* | 130.3 ± 7.9D | 135.6 ± 5.6L,R | 129.4 ± 16.8 | 132.2 ± 7.1 | 128.5 ± 7.2 |
| NLALS | 165.2 ± 10.8D | 163.8 ± 15.3 | 163.0 ± 16.8 | 162.7 ± 11.8L,T | 167.9 ± 3 | 169.2 ± 13.5 | 161.0 ± 15.4 |
| NAL2 | 141.9 ± 9.2D,L | 141.1 ± 6.2* | 142.2 ± 5.1D,L | 136.3 ± 5.6L,T,R | 144.0 ± 7.5 | 144.5 ± 5.3 | 144.8 ± 2.6 |
| Lymphocyte parameters | |||||||
| LV | 85.7 ± 5.4A,M,D,L,T | 91.5 ± 8.5 | 91.7 ± 9.2 | 90.9 ± 7.3 | 92.0 ± 9.3 | 92.5 ± 5.3 | 89.0 ± 3.2 |
| LC | 116.3 ± 6.8A,M,D,L,T | 108.7 ± 5.2 | 108.7 ± 4.7 | 108.4 ± 2.7 | 108.2 ± 9.1 | 110.7 ± 8.1 | 111.0 ± 3.6 |
| LMALS | 66.5 ± 13.1 M,D | 66.9 ± 6.9 | 66.2 ± 6.1L | 67.6 ± 6.8 | 68.2 ± 9.3 | 66.2 ± 6.9 | 67.3 ± 5.7 |
| LUMALS | 64 ± 14.6A | 67.5 ± 9.4* | 68.6 ± 9.6D | 65.2 ± 7.7L | 69.1 ± 11.5 | 65.3 ± 8.5 | 67.3 ± 6.1 |
| LLMALS | 60.4 ± 9.7 M | 60 ± 7.6* | 58.1±8D,L | 62.2 ± 6.7 | 61.5 ± 7.3 | 60.3 ± 4.9 | 61.5 ± 4.7 |
| LLALS | 35.9 ± 3.9A,M,D,L,T | 41.5 ± 7.5* | 41.5 ± 6.1D | 41.1 ± 19.4L,T | 42.7 ± 5 | 42.2 ± 2.6 | 40.3 ± 2.9 |
| LAL2 | 71.6 ± 6.6A,M,D,L,R | 68.0 ± 7.6* | 68.4 ± 9.6D | 66.8 ± 6.7 | 67.8 ± 6.4 | 71.2 ± .7.2 | 69.5 ± 4.2 |
| Monocyte parameters | |||||||
| MV | 167.5 ± 11.3A,M,D,L,R,T | 188.5 ± 14.5* | 191.4 ± 13.1D | 183.8±16L | 188.3 ± 13.9 | 189.9 ± 15.4 | 185.3 ± 6.7 |
| MC | 125.2 ± 7.1A,M,D,L,R,T | 117.6 ± 9.1* | 118.5 ± 6.4D | 117.2 ± 3.6 | 114.9 ± 19.1 | 121.1 ± 7.6 | 108.3 ± 18.2 |
| MMALS | 84.2 ± 10.4 M,D,L,T | 84.0 ± 5.2 | 83.9 ± 4.4 | 84.7 ± 5.1L,T | 83.2 ± 7.9 | 82.5 ± 2.9 | 82.7 ± 8.8 |
| MUMALS | 92 ± 10.7A,M,D,L,T | 89.0 ± 7.1* | 90.5 ± 5.3D | 86.1 ± 7.5L,T | 89.8 ± 10.2 | 90.2 ± 4.2 | 90.0 ± 8.7 |
| MLMALS | 72.1 ± 10.2A,D | 74.9 ± 5.8* | 73.6 ± 4.5D | 78.3 ± 5.8 T | 73.3 ± 6.8 | 72.1 ± 3.6 | 71.8 ± 10.1 |
| MLALS | 84.3 ± 14.2A,M,D,L | 95.0 ± 13.9* | 97.9 ± 13.8D,L | 91.7 ± 11.8 | 93.6 ± 14.7 | 91.9 ± 14.6 | 84.6 ± 31.5 |
| MAL2 | 128.4 ± 12.3A,M | 130.3 ± 12.8* | 132.6 ± 10.9D,L | 129.1 ± 13.7 | 126.7 ± 15 | 126.9 ± 13.2 | 121.0 ± 18.2 |
| Eosinophil parameters | |||||||
| EV | 154.3 ± 9.8A,L,D | 157.3 ± 14.5* | 159.0 ± 13.1L | 157.2 ± 15.8L | 152.1 ± 12.5 | 157.0 ± 24.3L | 152.0 ± 10.2 |
| EC | 152.3 ± 9.7A,M,D,L,R | 147. ±16.7* | 147.2 ± 10.1D | 144.7 ± 10.3 | 146.8 ± 9 | 170.0±65L | 144.3 ± 2.9 |
| EMALS | 2011.2±7A,M,L | 199.4 ± 13.6* | 199.0 ± 11.7D,L | 200.8±8L | 194.1 ± 11.5 | 214.1 ± 41.3L | 195.3 ± 6.9 |
| EUMALS | 211.8 ± 7.8A,M,L | 209.1 ± 13.8* | 208.9 ± 9.5D | 210.8 ± 10.2L | 201.9 ± 16.8 | 224.4 ± 38.3L | 207.0 ± 6.2 |
| ELMALS | 186 ± 7.4L | 186.1 ± 12.2* | 186.5 ± 8.5L | 185.9 ± 7.6L | 182.2 ± 7.7 | 197.8 ± 45.2L | 179.8 ± 7.6 |
| ELALS | 167.7 ± 12.1D | 168.8 ± 21.9 | 167.9 ± 18.4 | 168.3 ± 23.3 | 172.2 ± 18.1 | 174.5 ± 49.4L | 158.0 ± 23.9 |
| EAL2 | 120.6 ± 7.7A,M,L,D | 122.9 ± 7.9* | 121.5 ± 7.9D,L | 124.1 ± 7.1 | 125.3 ± 7.4 | 124.1 ± 10.7L,R | 121.5 ± 9.1 |
Comparison of SD value of the VCS parameters among the five infections
| VCS | Control | All | Malaria | Dengue | Leptospirosis | Typhoid | Rickettsia |
|---|---|---|---|---|---|---|---|
| Neutrophil parameters | |||||||
| NV‐SD | 16.6 ± 1.7A,M,D,L,R | 19.9 ± 4.8* | 19.3 ± 5.6D | 20.1 ± 2.7 T | 22.1 ± 5.3 | 17.8 ± 2.4L | 19.9 ± 2.6 |
| NC‐SD | 5±1D,T | 5.1 ± 1.4* | 5.08 ± 1.6D,T | 5.3 ± 1 T | 5.1 ± 1.3 | 4.4 ± 0.5L | 4.9 ± 0.7 |
| NMALS‐SD | 11 ± 1.8A,D,L | 11.6 ± 2.7* | 11.1 ± 2.2D,L | 12.2 ± 2.8 T | 12.8 ± 3.5 | 10.2 ± 1.2L | 11.4 ± 2.2 |
| NUMALS‐SD | 11.5 ± 1.6A,M,D,L | 12.3 ± 3.3* | 11.2 ± 2.2D,L | 13.8 ± 3.9 T | 13.6 ± 3.8 | 10.8 ± 1.2L | 12.1 ± 1.9 |
| NLMALS‐SD | 13.4 ± 2.4A,M,D,L | 14.3 ± 3.1* | 14.2 ± 2.8 T,L | 14.5 ± 3.5 T | 15.1 ± 3.2 | 12.3 ± 1.5L | 13.9 ± 3 |
| NLALS‐SD | 28.8 ± 4.1A,M,D,L | 31.3 ± 4.9* | 31.3 ± 5.2 T,L | 30.9 ± 3.7L,T | 33.1 ± 6.1 | 27.8 ± 2.6L | 30.7 ± 6.2 |
| NAL2‐SD | 10.6 ± 1.9A,M,D,L | 13.8 ± 3.9* | 13.9 ± 4 T,L | 13.1±3L,T | 15.9 ± 4.9 | 11.4±2L | 13.8 ± 4.5 |
| Lymphocyte parameters | |||||||
| LV‐SD | 14.8 ± 2.3A,M,D,L,T | 22.3 ± 5.2* | 23.4±8D,L,T,R | 21.4 ± 4 | 21.9 ± 7.7 | 19.7 ± 3.9 | 17.6 ± 3.8 |
| LC‐SD | 8.4 ± 1.9A,M,D,L,T | 12.0 ± 6.9* | 12.7 ± 6.1D,T | 11.1 ± 9.1L,T | 13.4 ± 7.3 | 7.1 ± 1.4L | 10.5 ± 4.5 |
| LMALS‐SD | 16.7 ± 1.5A,M,D,L | 19.2 ± 3.8* | 19.1 ± 3.6 T | 19.0 ± 3.2 T | 20.8 ± 5.6 | 16.7 ± 1.1L | 16.8 ± 1.3 |
| LUMALS‐SD | 20.4 ± 2.3A,M,D,L | 23.2 ± 4.9* | 23.3 ± 4.8 T | 23.1 ± 4.3 T | 24.4 ± 6.4 | 20.1 ± 1.8L | 20.3 ± 1.9 |
| LLMALS‐SD | 19.2 ± 1.4A,M,D,L | 21.8 ± 4.1* | 22.5 ± 4.5 T | 21.2 ± 3.3 T | 22.1 ± 4.1 | 18.3 ± 2.7L | 19.7 ± 1.8 |
| LLALS‐SD | 10.2 ± 1.1A,M,D,L,T,R | 14.1 ± 3.2* | 15.±3D,T,R | 12.8±3L | 14.8 ± 3.7 | 11.9 ± 1.8L | 11.7 ± 1.7L |
| LAL2‐SD | 11.5 ± 1.8A,M,DL | 14.7 ± 4.8* | 16.3±6D,L,T,R | 12.9 ± 1.9L | 13.9 ± 2.6 | 12.3 ± 2.4L | 11.3 ± 0.9L |
| Monocyte parameters | |||||||
| MV‐SD | 18.9 ± 2.9A,M,D,L,T,R | 27.5 ± 4.5* | 26.1 ± 3.9D,L,T | 29.7 ± 4.1 T | 28.8 ± 4.7 | 22.9±3L | 27.8 ± 8.7 |
| MC‐SD | 5.7 ± 2.1A,M,D,L,T | 9.1 ± 8.2* | 8.8 ± 7.7D | 7.9 ± 4.3 T | 13.1 ± 13.2 | 6.2 ± 1.3 | 16.2 ± 22.5 |
| MMALS‐SD | 12.1 ± 1.6A,D,L | 13.0 ± 2.5* | 12.4 ± 2.2D,L | 13.9±2L,T | 13.9 ± 3.7 | 12.1 ± 1.7 | 13.4 ± 3.5 |
| MUMALS‐SD | 12.7 ± 2.1A,M,D,L | 15.0 ± 4* | 13.3 ± 2.6D,L | 17.7 ± 4.1L,T | 15.4 ± 4.7 | 12.9 ± 2.7L | 14.5 ± 3 |
| MLMALS‐SD | 16 ± 2.2 M | 15.8 ± 3* | 15.4 ± 3.1D,L | 16.2 ± 2.7 | 16.6 ± 3.3 | 15.5 ± 1.7 | 16.6 ± 2.6 |
| MLALS‐SD | 26.6±4A,D,L,T | 28.6 ± 4.8* | 27.5 ± 4.3D,L,T | 28.8 ± 4.1L,T | 31.3 ± 6.5 | 31.8 ± 3.6 | 27.6 ± 4.4 |
| MAL2‐SD | 14.1 ± 2.7A,M,D,L | 19.4 ± 8.2* | 18.3 ± 7.7D,L,R | 21.3 ± 9.1 T | 22.0 ± 7.8 | 15.1±3L | 22.0 ± 12.9 |
| Eosinophil parameters | |||||||
| EV‐SD | 16.5 ± 2.9D,T | 16.5 ± 6.3* | 16.3 ± 5 T | 17.3 ± 7.3 T | 17.7 ± 7 | 10.9 ± 8 | 12.8 ± 6.2 |
| EC‐SD | 6.1 ± 5.3 M,D,L,T | 6.5 ± 8* | 7.1 ± 8.8 T | 6.3 ± 7.7 T | 6.0 ± 6.9 | 2.3 ± 1.7 | 4.3 ± 1.4 |
| EMALS‐SD | 8.8 ± 1.4 M,D,T | 8.4 ± 3.9* | 8.8 ± 3.8D,T | 7.6 ± 3.7L | 9.5 ± 3.8 | 5.5 ± 3.9 | 8.5 ± 5.5 |
| EUMALS‐SD | 9.9 ± 2.2 M,D,L,T | 9.6 ± 4.9* | 9.9 ± 4.8D,L,T | 8.6 ± 4.2L,T | 11.9 ± 5.6 | 5.6 ± 4.2 | 10.2 ± 4.8 |
| ELMALS‐SD | 10.8±2A,M,D,T | 9.7 ± 4.3 | 10.0 ± 4.22 | 9.4 ± 4.6L | 10.1 ± 3.2 | 6.8 ± 4.8 | 9.8 ± 5.8 |
| ELALS‐SD | 42.1 ± 4.9A,M,L,T | 38.2 ± 12.7* | 38.1 ± 11.7D | 39.9 ± 13.5 T | 38.1 ± 11.1 | 26.8 ± 19.1 | 37.8 ± 8.3 |
| EAL2‐SD | 9.7 ± 2.9L,T,R | 9.9 ± 4.3* | 9.7±4L,T | 9.9±4L,T,R | 11.6 ± 4.6 | 6.1 ± 4.5 | 15.3 ± 4.9 |